colon cancer
Conditions
Interventions
study group:TAP with 20 mL of ropivacaine 0.375% plus 2mL of DEX (1µg/kg)
control group:TAP with 20 mL of ropivacaine 0.375% plus 2mL normal saline
Sponsors
The Affiliated Yantai Yuhuangding Hospital of Qingdao Medical College
Eligibility
Sex/Gender
All
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: 70 ASA I-II patients (aged 25-65 years, weighted 52-83 kg) scheduled for laparoscopic radical operation on colon under general anaesthesia were registered.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had a history of allergy to the drugs used in this study, psychological disorders, infection of the block injection site or any other contraindications for TAPB, tolerance to opioids or if they had used opioids within 48 h prior to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| resting VAS pain score;VAS score after exercise; | — |
Secondary
| Measure | Time frame |
|---|---|
| The highest level of sensory block;duration of sensory block;the duration of analgesia;sedation score; | — |
Countries
China
Contacts
Public ContactMa Jiahai
The Affiliated Yantai Yuhuangding Hospital of Qingdao Medical College
Outcome results
None listed